Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study

1. Trillsch, F.
2. Mahner, S.
3. Ataseven, B.
4. Asher, R.
5. Aryal, N.
6. Dubot, C.
7. Clamp, A.
8. Penson, R.T.
9. Oza, A.
10. Amit, A.
11. Huzarski, T.
12. Casado, A.
13. Scambia, G.
14. Friedlander, M.
15. Colombo, N.
16. Fujiwara, K.
17. Sonke, G.S.
18. Denys, H.
19. Lowe, E.S.
20. Lee, C.K.
21. Pujade-Lauraine, E.